These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 230063

  • 1. Demonstration of the crucial role of the phenylalanine moiety in enkephalin analogues for differential recognition of the mu- and delta-receptors.
    Roques BP, Gacel G, Fournie-Zaluski MC, Senault B, Lecomte JM.
    Eur J Pharmacol; 1979 Nov 23; 60(1):109-10. PubMed ID: 230063
    [No Abstract] [Full Text] [Related]

  • 2. Correlation between circular dichroism data and biological activities of 2,5 substituted enkephalin analogues.
    Soós J, Berzétei I, Bajusz S, Rónai AZ.
    Life Sci; 1980 Jul 14; 27(2):129-33. PubMed ID: 6249995
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro profile of some opioid pentapeptide analogues.
    Shaw JS, Turnbull MJ.
    Eur J Pharmacol; 1978 Jun 01; 49(3):313-7. PubMed ID: 658147
    [Abstract] [Full Text] [Related]

  • 5. In vitro evaluation of a casomorphin related pentapeptide, a competitive mu opioid receptor antagonist.
    Davis P, Tourwe D, Delaet N, Kramer TH, Burks TF.
    Proc West Pharmacol Soc; 1991 Jun 01; 34():429-32. PubMed ID: 1664962
    [No Abstract] [Full Text] [Related]

  • 6. Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors: correlation with analgesia.
    Audigier Y, Mazarguil H, Gout R, Cros J.
    Eur J Pharmacol; 1980 Apr 11; 63(1):35-46. PubMed ID: 6247160
    [Abstract] [Full Text] [Related]

  • 7. Comparison of biological activities of enkephalin analogues in isolated organs.
    Friedmann T, Medzihradszky K, Kovács A, Kerecsen L, Szécsi JH, Di Gléria K, Knoll J.
    Pol J Pharmacol Pharm; 1982 Apr 11; 34(1-3):53-61. PubMed ID: 6300815
    [No Abstract] [Full Text] [Related]

  • 8. Comparative effects of somatostatin and enkephalins on the guinea pig ileum and the rat vas deferens.
    Jhamandas K, Elliott J.
    Can J Physiol Pharmacol; 1980 Nov 11; 58(11):1389-92. PubMed ID: 6111385
    [Abstract] [Full Text] [Related]

  • 9. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM, Chavkin C.
    Mol Pharmacol; 1983 Jan 11; 23(1):36-43. PubMed ID: 6135144
    [No Abstract] [Full Text] [Related]

  • 10. In vitro study of the interaction of salmon calcitonin with mu, delta and kappa opioid agonists.
    Martín MI, Alfaro MJ, Goicoechea C, Colado MI.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar 11; 347(3):324-8. PubMed ID: 8386807
    [Abstract] [Full Text] [Related]

  • 11. The choice of opiate receptor subtype by neo-endorphins.
    Oka T, Negishi K, Kajiwara M, Watanabe Y, Ishizuka Y, Matsumiya T.
    Eur J Pharmacol; 1982 Apr 23; 79(3-4):301-5. PubMed ID: 6284522
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and biological activity of beta-endorphin and analogues. Additional evidence for multiple opiate receptors.
    Lemaire S, Bérubé A, Derome G, Lemaire I, Magnan J, Regoli D, St Pierre S.
    J Med Chem; 1978 Dec 23; 21(12):1232-5. PubMed ID: 214559
    [No Abstract] [Full Text] [Related]

  • 13. The in vitro pharmacology of D-Met2,Pro5-enkephalinamide.
    Rónai AZ, Berzétei IP, Bajusz S, Székely JI.
    J Pharm Pharmacol; 1981 Aug 23; 33(8):534-5. PubMed ID: 6115930
    [No Abstract] [Full Text] [Related]

  • 14. In vitro pharmacology of the opioid peptides, enkephalins and endorphins.
    Waterfield AA, Smokcum RW, Hughes J, Kosterlitz HW, Henderson G.
    Eur J Pharmacol; 1977 May 15; 43(2):107-16. PubMed ID: 17538
    [Abstract] [Full Text] [Related]

  • 15. Opioid peptides derived from pre-proenkephalin B sequence: biological evaluation in guinea pig ileum and mouse vas deferens.
    Sánchez-Blázquez P, Garzón J, Lee NM.
    Proc West Pharmacol Soc; 1983 May 15; 26():85-8. PubMed ID: 6688470
    [No Abstract] [Full Text] [Related]

  • 16. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.
    Corbett AD, Gillan MG, Kosterlitz HW, McKnight AT, Paterson SJ, Robson LE.
    Br J Pharmacol; 1984 Sep 15; 83(1):271-9. PubMed ID: 6091824
    [Abstract] [Full Text] [Related]

  • 17. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N, Milanov P, Vezenkov L, Pajpanova T, Naydenova E.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):249-56. PubMed ID: 15364002
    [Abstract] [Full Text] [Related]

  • 18. Lack of cross-tolerance between morphine and Leu-enkephalin in the mouse vas deferens.
    Illes P, Zieglgänsberger W, Herz A.
    Brain Res; 1980 Sep 15; 197(1):260-3. PubMed ID: 6249458
    [No Abstract] [Full Text] [Related]

  • 19. Conformation and biological activities of hexapeptides related to enkephalins: respective roles of the ammonium and hydroxyl groups of tyrosine.
    Gacel G, Fournié-Zaluski MC, Fellion E, Roques BP, Senault B, Lecomte JM, Malfroy B, Swerts JP, Schwartz JC.
    Life Sci; 1979 Feb 19; 24(8):725-31. PubMed ID: 440018
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of the action of putative endogenous kappa-agonists, leumorphin and rimorphin in vitro.
    Suda M, Nakao K, Yoshimasa T, Ikeda Y, Sakamoto M, Yanaihara C, Yanaihara N, Numa S, Imura H.
    Life Sci; 1983 Feb 19; 33 Suppl 1():275-8. PubMed ID: 6319876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.